Skip to content
OpenCapital
Get started

Weis Markets WMK Pharmacy — Revenue

Other product segments

Grocery
$1.02B+2.4%
Fuel Product
$67.83M+26.8%
Service
$4.19M+5.6%
Manufacturing
$2.25M+5.8%

Similar metrics at other companies

BrightSpring Health Services, Inc. logo
BTSGPharmacy Solutions — Revenue
$3.17B+25.2%
Nuvation Bio logo
NUVBProduct Revenue — Revenue
$18.5M+2,213%
Kiniksa Pharmaceuticals International, plc logo
KNSAProduct — Revenue
$214.27M+55.5%
Syndax Pharmaceuticals logo
SNDXProduct — Revenue
$48.92M+144%
PTC Therapeutics logo
PTCTProduct — Revenue
$225.57M+47.0%
CVS Health logo
CVSPharmacy — Revenues from external customers
$56.94B+8.4%

Other financials

Income statement

See full
Revenue$1.3B+4.6%
Gross profit$330.2M+10.7%
Operating income$35.7M+64.0%
Net income$27.9M+42.5%
EPS (diluted)$1.13+54.8%

Balance sheet

See full
Cash & equivalents$97.7M-41.8%
Total debt$173.8M+3.2%
Total equity$1.4B-5.1%
Total assets$2.0B-1.8%

Cash flow

See full
Operating cash flow$30.2M+523%
CapEx$39.3M+18.5%
Free cash flow-$9.1M+68.0%

Valuation

See full
Market cap$1.95B-18.3%
Enterprise value$2.03B-14.7%
P/E19.2×-4.0×
P/S0.4×-0.1×

Profitability

See full
Gross margin25.4%+0.4pp
Operating margin2.5%0.0pp
Net margin2%-0.1pp
FCF margin0.5%+0.5pp

Returns & leverage

See full
Return on equity7.2%0.0pp
Debt / equity0.1×0.0×
Current ratio2×-0.4×

Where this comes from

Reported directly by Weis Markets in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Weis Markets’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Weis Markets's pharmacy — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Weis Markets's pharmacy — revenue?
Weis Markets (WMK) reported pharmacy — revenue of $165.04M in Q1 2026.
How has Weis Markets's pharmacy — revenue changed year-over-year?
Weis Markets's pharmacy — revenue increased by 11.4% year-over-year, from $148.09M to $165.04M.
What is the long-term trend for Weis Markets's pharmacy — revenue?
Over 4 years (2021 to 2025), Weis Markets's pharmacy — revenue has grown at a 13.9% compound annual growth rate (CAGR), from $399.13M to $671.75M.
What does pharmacy — revenue mean?
This metric represents the total net revenue generated from pharmacy operations, excluding any assessed taxes collected from customers. It serves as a primary indicator of the pharmacy segment's market demand and its contribution to the company's overall retail footprint. Growth in this figure reflects successful customer acquisition, expanded service offerings, or increased prescription volume within the retail pharmacy channel.